As shown in Figure 6F, the ratio of the microtubule-associated protein 1A/1B-light chain 3 (LC3) B-II/I was significantly reduced in the HF-HFr group, with CAF or GCE treatment not reversing this decrease. This evidence concerns the gene MAP1A and hydrops fetalis.